Results 11 to 20 of about 655,517 (311)

Efficacy of BEAM versus BeEAM conditioning regimens in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: a retrospective single-center study [PDF]

open access: yesFrontiers in Oncology
The BEAM regimen (carmustine, etoposide, cytarabine, melphalan) is the standard conditioning regimen for autologous hematopoietic stem cell transplantation (auto-HSCT) in diffuse large B-cell lymphoma (DLBCL).
Saibiya Akebaer   +8 more
doaj   +2 more sources

Combining Mobilizing Agents with Busulfan to Reduce Chemotherapy-Based Conditioning for Hematopoietic Stem Cell Transplantation

open access: yesCells, 2021
In the context of hematopoietic stem cell (HSC) transplantation, conditioning with myelo- and immune-ablative agents is used to eradicate the patient’s diseased cells, generate space in the marrow and suppress immune reactions prior to the infusion of ...
Laura Garcia-Perez   +5 more
doaj   +3 more sources

Oxyfertigation and Transplanting Conditions of Strawberries [PDF]

open access: yesAgronomy, 2021
Soilless growing systems can improve water-use efficiency, especially in closed soilless growing systems. The main purpose of this study was to evaluate the effects of different transplanting conditions, and determine how supplying H2O2 as an oxygen source to the rhizosphere of strawberry plants in a soilless growing system affects plant growth, fruit ...
Pedro Palencia   +2 more
openaire   +4 more sources

Outcomes of Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma Patients at a Tertiary Referral Centre [PDF]

open access: yesMiddle East Journal of Cancer, 2023
Background: Autologous stem cell transplant (ASCT) has been used as a consolidative treatment modality in non-Hodgkin’s lymphoma (NHL), but its role in NHL management is still evolving.
Ajay Prakash, Hugh Goodman
doaj   +1 more source

Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies

open access: yesFrontiers in Oncology, 2022
Conditioning regimens play a crucial role in preventing relapse of acute myeloid leukemia (AML) following allogeneic hematopoietic cell transplantation (HCT).
Masamitsu Yanada   +4 more
doaj   +1 more source

Risk factors for alcohol recidivism after liver transplantation [PDF]

open access: yes, 2021
Go to Background: Alcoholic liver disease (ALD) has been increasing recently and the second most common indication for liver transplantation (LT) in Korea.
이재근   +8 more
core   +1 more source

Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation [PDF]

open access: yesBlood, 2022
Abstract The intensity of the conditioning regimen given before allogeneic hematopoietic cell transplantation (allo-HCT) can vary substantially. To confirm the ability of the recently developed transplant conditioning intensity (TCI) score to stratify the preparative regimens of allo-HCT, we used an independent and contemporary patient cohort ...
Alexandros Spyridonidis   +29 more
openaire   +9 more sources

Improving self-sufficiency in organ transplantation in Korea [PDF]

open access: yes, 2021
After attaining a qualified medical capacity in organ transplantation, Korea has been struggling to increase the number of deceased organ transplants to reach self-sufficiency.
김명수, 김순일
core   +1 more source

Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation [PDF]

open access: yes, 2023
: For acute lymphoblastic leukemia (ALL) patients, total body irradiation (TBI)- based conditioning regimens are the first choice specially in young population.
Sestili, Simona   +17 more
core   +1 more source

Personalized prediction of overall survival in patients with AML in non‐complete remission undergoing allo‐HCT

open access: yesCancer Medicine, 2021
Allogenic hematopoietic stem cell transplantation (allo‐HCT) is the standard treatment for acute myeloid leukemia (AML) in non‐complete remission (non‐CR); however, the prognosis is inconsistent.
Shigeki Hirabayashi   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy